IRBM/Merck Research Laboratories, 00040 Pomezia, Italy.
Bioorg Med Chem Lett. 2010 Feb 1;20(3):1094-9. doi: 10.1016/j.bmcl.2009.12.026. Epub 2009 Dec 6.
Herein we describe the discovery of a novel series of pyrrolo[1,2-a]pyrazin-1(2H)-one PARP inhibitors. Optimization led to compounds that display excellent PARP-1 enzyme potency and inhibit the proliferation of BRCA deficient cells in the low double-digit nanomolar range showing excellent selectivity over BRCA proficient cancer cells.
在此,我们描述了一系列新型吡咯并[1,2-a]吡嗪-1(2H)-酮 PARP 抑制剂的发现。通过优化得到的化合物对 PARP-1 酶具有优异的抑制活性,在低双位数纳摩尔范围内抑制 BRCA 缺陷细胞的增殖,对 BRCA 功能正常的癌细胞具有优异的选择性。